Who owns the UNIVERSAL CANCER IMMUNOTHERAPY trademark?

The UNIVERSAL CANCER IMMUNOTHERAPY trademark is owned by ImmunityBio, Inc..

What class is the UNIVERSAL CANCER IMMUNOTHERAPY trademark registered in?

The UNIVERSAL CANCER IMMUNOTHERAPY trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for UNIVERSAL CANCER IMMUNOTHERAPY?

The USPTO serial number for UNIVERSAL CANCER IMMUNOTHERAPY is 99053458.

What is the registration number for UNIVERSAL CANCER IMMUNOTHERAPY?

UNIVERSAL CANCER IMMUNOTHERAPY is registered under USPTO registration number 0.

UNI

USPTO Trademark Record

PENDING

UNIVERSAL CANCER IMMUNOTHERAPY

SN 99053458·Reg 0·Filed Feb 24, 2025

Owner ImmunityBio, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

UNIVERSAL CANCER IMMUNOTHERAPY (Serial No. 99053458), Registration No. 0, is a pending US trademark filed on Feb 24, 2025 by ImmunityBio, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Deadline expired: September 15, 2026

Mark Intelligence

UNIVERSAL CANCER IMMUNOTHERAPY (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Feb 24, 2025

SERIAL

99053458

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

ImmunityBio, Inc.

Entity

Corporation

State

Address

3530 John Hopkins Court, San Diego, CA, 92121

Country

Attorney

NameALICIA M. PASSERIN

Law firm

ALICIA M. PASSERIN Leech Tishman Fuscaldo & Lampl, LLC

Docket

IBIO-98

Address

525 William Penn Place, 28th Floor, Pittsburgh, PA 15219, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateFeb 24, 2025

Serial Number99053458

Registration No.0

Registration DateDec 31, 1969

Status DateMar 15, 2026

Mark TypeStandard characters

Attorney DocketIBIO-98

Status DescriptionLive and pending, non-final action mailed

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

28 events

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Jun 15, 2026

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Jun 15, 2026

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

NON-FINAL ACTION WRITTEN

Mar 15, 2026

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 15, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 15, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO LIE

Mar 03, 2026

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 03, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 03, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

EXPARTE APPEAL RECEIVED AT TTAB

Mar 02, 2026

EXPARTE APPEAL RECEIVED AT TTAB

JURISDICTION RESTORED TO EXAMINING ATTORNEY

Mar 02, 2026

JURISDICTION RESTORED TO EXAMINING ATTORNEY

EX PARTE APPEAL-INSTITUTED

Mar 02, 2026

EX PARTE APPEAL-INSTITUTED

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Mar 02, 2026

TEAS REQUEST FOR RECONSIDERATION RECEIVED

ASSIGNED TO EXAMINER

Jan 28, 2026

ASSIGNED TO EXAMINER

FINAL REFUSAL WRITTEN

Dec 01, 2025

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Dec 01, 2025

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Dec 01, 2025

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 17, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 17, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 17, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Aug 14, 2025

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Aug 14, 2025

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

ASSIGNED TO EXAMINER

May 15, 2025

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

May 15, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 15, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 15, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION ENTERED

Feb 24, 2025

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 24, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Feb 24, 2025

APPLICATION FILING RECEIPT MAILED

UNIVERSAL CANCER IMMUNOTHERAPY

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by ImmunityBio, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by ALICIA M. PASSERIN

Resources

Company